Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Healthcare Biotechnology
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

ACADIA Pharmaceuticals to Present at the 24th Annual Credit Suisse Healthcare Conference on November 10, 2015

Business Wire November 4, 2015

ACADIA Pharmaceuticals Announces FDA Priority Review of NUPLAZID(TM) (Pimavanserin) New Drug Application for Parkinson's Disease Psychosis

Business Wire November 2, 2015

ACADIA Pharmaceuticals to Announce Third Quarter Financial Results on November 5, 2015

Business Wire October 29, 2015

ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2015 Healthcare Conference on September 29, 2015

Business Wire September 22, 2015

ACADIA Pharmaceuticals Appoints Steve Davis as Chief Executive Officer

Business Wire September 3, 2015

ACADIA Pharmaceuticals Submits New Drug Application for NUPLAZID(TM) for the Treatment of Parkinson's Disease Psychosis

Business Wire September 3, 2015

ACADIA Pharmaceuticals Reports Second Quarter 2015 Financial Results

Business Wire August 6, 2015

ACADIA Pharmaceuticals Announces Publication of Data from Its -015 Open Label Safety Study in Parkinson's Disease Psychosis in the Journal of the American Medical Directors Association

Business Wire August 6, 2015

ACADIA Pharmaceuticals Announces Senior Management Appointments in Manufacturing, Quality, Compliance, Access and Reimbursement and Business Development

Business Wire August 5, 2015

ACADIA Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2015

Business Wire July 30, 2015

ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 24, 2015

Business Wire June 17, 2015

ACADIA Pharmaceuticals Presents Integrated Data from Its Phase III Program with NUPLAZID(TM) (Pimavanserin) for Parkinson's Disease Psychosis at the 19th International Congress of Parkinson's Disease and Movement Disorders

Business Wire June 16, 2015

ACADIA Pharmaceuticals to Present at the Jefferies 2015 Healthcare Conference on June 2, 2015

Business Wire May 26, 2015

ACADIA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Acadia Pharmaceuticals, Inc. (ACAD) to Contact the Firm Before the Imminent Lead Plaintiff Deadline

GlobeNewswire May 9, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD

PR Newswire May 8, 2015

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 -- ACAD

GlobeNewswire May 8, 2015

ACADIA Pharmaceuticals Reports First Quarter 2015 Financial Results

Business Wire May 7, 2015

ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 13, 2015

Business Wire May 6, 2015

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of ACADIA Pharmaceuticals Inc. Of Upcoming Deadline

Business Wire May 4, 2015

ACADIA Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2015

Business Wire April 30, 2015